| Market Cap | ₹26Cr | 
| ROE | 2.90% | 
| P/E Ratio(TTM) | 13.10 | 
| EPS(TTM) | 1.42 | 
| P/B Ratio | 0.38 | 
| Dividend Yield | 0.00% | 
| Industry P/E | 85.69 | 
| Book Value | 49.05 | 
| Debt to Equity | 0.16 | 
| Face Value | 10 | 
| Parent Organisation | Nidan Laboratories And Healthcare | 
| NSE Symbol | NIDAN | 
| COMPANY | 52 WEEK  | MARKET PRICE | P/E Ratio  | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%)  | 48.69  | ||
| Metropolis Healthcare | NA (0.00%)  | 66.72  | ||
| Vijaya Diagnostic Centre | NA (0.00%)  | 67.14  | ||
| Thyrocare Technologies | NA (0.00%)  | 58.51  |